Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 31, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Daina Graybosch Upgraded (TSVT) to Buy and Increased Target to $18 on, Jan 31st, 2024
Daina Graybosch of Leerink Partners, Upgraded "2seventy bio, Inc." (TSVT) to Buy and Increased Target from $5 to $18 on, Jan 31st, 2024.
Daina has made no other calls on TSVT in the last 4 months.
There are 2 other peers that have a rating on TSVT. Out of the 2 peers that are also analyzing TSVT, 1 agrees with Daina's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Downgraded from Buy to Hold and Held Target at $2 on, Monday, November 20th, 2023
This is the rating of the analyst that currently disagrees with Daina
- Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $13 on, Thursday, October 12th, 2023
